Scegli un formato
| A voi/SKU | Disponibilità | Prezzo |
|---|---|---|
50 mg | Per conoscere la disponibilità, visualizza il carrello | CHF 1’310.00 |
Informazioni su questo articolo
grade
pharmaceutical primary standard
agency
USP
API family
buspirone
manufacturer/tradename
USP
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
2-8°C
SMILES string
N1C(=O)CC2(CCCC2)CC1=O
InChI
1S/C9H13NO2/c11-7-5-9(3-1-2-4-9)6-8(12)10-7/h1-6H2,(H,10,11,12)
InChI key
YRTHJMQKDCXPAY-UHFFFAOYSA-N
General description
For further information and support please go to the website of the issuing Pharmacopoeia.
Application
- Buspirone Hydrochloride
- Buspirone Hydrochloride Tablets
Analysis Note
Other Notes
1 of 1
Questo articolo | |||
|---|---|---|---|
| manufacturer/tradename USP | manufacturer/tradename USP | manufacturer/tradename - | manufacturer/tradename USP |
| grade pharmaceutical primary standard | grade pharmaceutical primary standard | grade certified reference material, pharmaceutical secondary standard | grade pharmaceutical primary standard |
| application(s) pharmaceutical (small molecule) | application(s) pharmaceutical (small molecule) | application(s) pharmaceutical small molecule | application(s) pharmaceutical (small molecule) |
| format neat | format neat | format - | format neat |
| API family buspirone | API family buspirone | API family buspirone | API family buspirone |
| storage temp. 2-8°C | storage temp. 2-8°C | storage temp. 2-8°C | storage temp. 2-8°C |
Still not finding the right product?
Explore all of our products under Buspirone Related Compound K
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 3 Oral - Aquatic Chronic 2
Classe di stoccaggio
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Scegli una delle versioni più recenti:
Possiedi già questo prodotto?
I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.




